文献速递皮肤肿瘤

患者对人工智能用于皮肤癌筛查的看法:一项定性研究

Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study.
PubMed 文献 · JAMA Dermatol · 2020-01-01

该定性研究通过半结构化访谈48名皮肤科患者,探讨其对人工智能(AI)用于皮肤癌筛查的认知与态度。患者主要将AI理解为认知工具,最常感知的益处是提高诊断速度和医疗可及性,最大风险是增加患者焦虑。多数患者重视人机协同,75%愿意向亲友推荐AI。

要点

  • 患者对AI用于皮肤癌筛查总体接受度较高,但强调需保持医患关系完整性。
  • 患者最常感知的益处为诊断速度提升和医疗可及性改善(各60%)。
  • 患者最担心AI增加焦虑(40%),且人机决策冲突时多数选择活检(67%)。

核心结论

  • 患者对AI用于皮肤癌筛查持接受态度,前提是实施方式能保持人类医患关系的完整性。

研究设计与样本

  • 采用扎根理论的定性研究,在布莱根妇女医院和丹娜-法伯癌症研究所的皮肤科门诊招募48名患者进行半结构化访谈。
  • 研究于2019年5月6日至7月8日进行,每份访谈由2名研究者独立编码,编码者间信度κ=0.94和κ=0.89。

主要发现

  • 48名患者中女性26人(54%),平均年龄53.3(标准差21.7)岁;16人(33%)有黑色素瘤史,16人(33%)仅有非黑色素瘤皮肤癌史,16人(33%)无皮肤癌史。
  • 24名患者接受关于直接面向患者AI工具的访谈,24名接受关于临床医生决策支持AI工具的访谈。
  • 患者最常感知的益处是提高诊断速度(29人[60%])和医疗可及性(29人[60%]),最常感知的风险是增加患者焦虑(19人[40%])。
  • 患者认为AI的最大优势是更准确诊断(33人[69%]),最大劣势是诊断不够准确(41人[85%]);主导主题是人机共生的重要性(45人[94%])。
  • 人机临床决策冲突时最常见回应是寻求活检(32人[67%]);总体36名患者(75%)会向亲友推荐AI。

临床怎么用

  • 临床引入AI皮肤癌筛查工具时,应重视患者对人机协同的期待,并关注可能引发的焦虑。
  • 向患者解释AI辅助决策时,需明确人类医生在最终决策中的作用,以维护医患信任。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The use of artificial intelligence (AI) is expanding throughout the field of medicine. In dermatology, researchers are evaluating the potential for direct-to-patient and clinician decision-support AI tools to classify skin lesions. Although AI is poised to change how patients engage in health care, patient perspectives remain poorly understood. OBJECTIVE: To explore how patients conceptualize AI and perceive the use of AI for skin cancer screening. DESIGN, SETTING, AND PARTICIPANTS: A qualitative study using a grounded theory approach to semistructured interview analysis was conducted in general dermatology clinics at the Brigham and Women's Hospital and melanoma clinics at the Dana-Farber Cancer Institute. Forty-eight patients were enrolled. Each interview was independently coded by 2 researchers with interrater reliability measurement; reconciled codes were used to assess code frequency. The study was conducted from May 6 to July 8, 2019. MAIN OUTCOMES AND MEASURES: Artificial intelligence concept, perceived benefits and risks of AI, strengths and weaknesses of AI, AI implementation, response to conflict between human and AI clinical decision-making, and recommendation for or against AI. RESULTS: Of 48 patients enrolled, 26 participants (54%) were women; mean (SD) age was 53.3 (21.7) years. Sixteen patients (33%) had a history of melanoma, 16 patients (33%) had a history of nonmelanoma skin cancer only, and 16 patients (33%) had no history of skin cancer. Twenty-four patients were interviewed about a direct-to-patient AI tool and 24 patients were interviewed about a clinician decision-support AI tool. Interrater reliability ratings for the 2 coding teams were κ = 0.94 and κ = 0.89. Patients primarily conceptualized AI in terms of cognition. Increased diagnostic speed (29 participants [60%]) and health care access (29 [60%]) were the most commonly perceived benefits of AI for skin cancer screening; increased patient anxiety was the most commonly perceived risk (19 [40%]). Patients perceived both more accurate diagnosis (33 [69%]) and less accurate diagnosis (41 [85%]) to be the greatest strength and weakness of AI, respectively. The dominant theme that emerged was the importance of symbiosis between humans and AI (45 [94%]). Seeking biopsy was the most common response to conflict between human and AI clinical decision-making (32 [67%]). Overall, 36 patients (75%) would recommend AI to family members and friends. CONCLUSIONS AND RELEVANCE: In this qualitative study, patients appeared to be receptive to the use of AI for skin cancer screening if implemented in a manner that preserves the integrity of the human physician-patient relationship.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Nelson CA, Pérez-Chada LM, Creadore A, et al. Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study. JAMA Dermatol. 2020. PMID: 32159733. doi:10.1001/jamadermatol.2019.5014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。